Literature DB >> 23969075

Increased level of interleukin-13, but not interleukin-4 and interferon-γ in chronic rhinosinusitis with nasal polyps.

M Nabavi1, S Arshi1, A Bahrami2, Z Aryan3, M H Bemanian1, H Esmaeilzadeh1, F Jalali1, S B Pousti4, N Rezaei5.   

Abstract

BACKGROUND: This study was performed to investigate the serum level of interleukin (IL)-13, IL-4, and interferon (IFN)-γ in chronic rhinosinusitis with nasal polyps (CRSwNP) and subsequent inflammation pattern and comorbidities including asthma and aspirin intolerance.
METHODS: A case-control study was conducted on 60 adult patients with CRSwNP with mean age of 37.7±12.7 (ranging from 18 to 70) years, and on 20 healthy controls. Serum levels of IL-13, IL-4, and IFN-γ were assessed, using enzyme-linked immunosorbent assay to be compared between case and control groups. Serum level of total immunoglobulin (Ig) E was also assessed in the patients with CRSwNP.
RESULTS: Serum level of IL-13 in the patients with CRSwNP was significantly higher than the controls (0.98±1.56 vs. 0.34±0.16 pg/ml, respectively, p=0.002). IL-4 and IFN-γ did not differ significantly between the two groups. Total IgE level was significantly increased in the patients with CRSwNP, compared to the normal values (301.43±516.54 IU/ml, p=0.033). Among the patients with CRSwNP, 12/60 (20%) had aspirin intolerance and 44/60 (73.3%) had asthma. IgE was also higher in asthmatics than non-asthmatics patients (364.9±586.6 vs. 126.7±135.7, respectively, p=0.015). Patients with aspirin intolerance had higher levels of IFN-γ (4.7±1.4 vs. 4.1±0.6, respectively, p=0.022).
CONCLUSIONS: IL-13 with high level of total IgE was observed in the patients with CRSwNP, which predisposes them to have concomitant asthma. IFN-γ seems to be down-regulated in the patients with CRSwNP, but could be over-expressed in the presence of aspirin intolerance.
Copyright © 2013 SEICAP. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Asthma; Chronic rhinosinusitis; Interleukin; Nasal polyps

Mesh:

Substances:

Year:  2013        PMID: 23969075     DOI: 10.1016/j.aller.2013.06.007

Source DB:  PubMed          Journal:  Allergol Immunopathol (Madr)        ISSN: 0301-0546            Impact factor:   1.667


  4 in total

1.  Mucus T helper 2 biomarkers predict chronic rhinosinusitis disease severity and prior surgical intervention.

Authors:  Justin H Turner; Ping Li; Rakesh K Chandra
Journal:  Int Forum Allergy Rhinol       Date:  2018-06-08       Impact factor: 3.858

2.  TMEM16A-Mediated Mucin Secretion in IL-13-Induced Nasal Epithelial Cells From Chronic Rhinosinusitis Patients.

Authors:  Yu Zhang; Xiangdong Wang; Hong Wang; Jian Jiao; Ying Li; Erzhong Fan; Luo Zhang; Claus Bachert
Journal:  Allergy Asthma Immunol Res       Date:  2015-03-05       Impact factor: 5.764

Review 3.  Subtyping of polyposis nasi: phenotypes, endotypes and comorbidities.

Authors:  Michael Koennecke; Ludger Klimek; Joaquim Mullol; Philippe Gevaert; Barbara Wollenberg
Journal:  Allergo J Int       Date:  2018-01-22

4.  Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping.

Authors:  Reza Kaboodkhani; Amirreza Bolkheir; Hossein Esmaeilzadeh; Mohammad Faramarzi; Mohammadjavad Ashraf; Milad Hosseinialhashemi; Negar Mortazavi; Narjes Ebrahimi
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.